Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.09.2023 | Case report

Methylprednisolone/tozinameran

Unmasking of neuromyelitis optica spectrum disorder and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Shirah B, et al. Optic Neuritis Following the BNT162b2 mRNA COVID-19 Vaccine in a Patient with Systemic Lupus Erythematosus Uncovering the Diagnosis of Neuromyelitis Optica Spectrum Disorders. Ocular Immunology and Inflammation 31 : 1213-1215, No. 6, 2023. Available from: URL: http://doi.org/10.1080/09273948.2022.2089901 Shirah B, et al. Optic Neuritis Following the BNT162b2 mRNA COVID-19 Vaccine in a Patient with Systemic Lupus Erythematosus Uncovering the Diagnosis of Neuromyelitis Optica Spectrum Disorders. Ocular Immunology and Inflammation 31 : 1213-1215, No. 6, 2023. Available from: URL: http://​doi.​org/​10.​1080/​09273948.​2022.​2089901
Metadaten
Titel
Methylprednisolone/tozinameran
Unmasking of neuromyelitis optica spectrum disorder and lack of efficacy: case report
Publikationsdatum
01.09.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-45907-2

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Antineoplastics

Case report

Antibacterials